When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Thinly traded micro cap resTORbio (TORC+1.5%) is up on below-average volume in response to the release of more data from a Phase 2b clinical trial evaluating lead candidate RTB101 in patients at least 65 years old at high risk of respiratory tract infections (RTIs). The results are being presented today at the American Thoracic Society International Conference in Dallas, TX.
More news on: resTORbio, Inc., Healthcare stocks news, Stocks on the move,